Cc1oc2c(C)c3oc(=O)c(CCC(=O)N4C[C@@H]5C[C@H](C4)Cn4c5cccc4=O)c(C)c3cc2c1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?